Depletion of p31 comet protein promotes sensitivity to antimitotic drugs

Journal of Biological Chemistry

Volumn 287, Issue 25, 2012, Pages 21561-21569

  Ma, Hoi Tang ^a   Chan, Yan Yan ^a   Chen, Xiao ^a,b   On, Kin Fan ^a,c   Poon, Randy Y C ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^b PRINCETON UNIVERSITY   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEINS; CANCER CELL LINES; CELL LINES; CHEMOTHERAPEUTIC AGENTS; DOWN-REGULATION; MITOTIC CELLS; NOCODAZOLE; SPINDLE-ASSEMBLY;

CELL DEATH;

CELL CULTURE;

ANTIMITOTIC AGENT; CARRIER PROTEIN; NOCODAZOLE; PACLITAXEL; PROTEIN MAD2; PROTEIN P31; UNCLASSIFIED DRUG; VINCRISTINE; ANTINEOPLASTIC AGENT; CELL CYCLE PROTEIN; CYTOSTATIC AGENT; MAD2L1BP PROTEIN, HUMAN; NUCLEAR PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL CYCLE CHECKPOINT; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; CYTOTOXICITY; DOWN REGULATION; DRUG SENSITIVITY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MITOSIS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; CELL STRAIN HEPG2; CENTROMERE; DRUG EFFECT; DRUG RESISTANCE; GENETICS; HELA CELL; METABOLISM; MITOSIS SPINDLE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANTINEOPLASTIC AGENTS; CELL CYCLE PROTEINS; CYTOSTATIC AGENTS; DRUG RESISTANCE, NEOPLASM; HELA CELLS; HEP G2 CELLS; HUMANS; KINETOCHORES; MITOTIC SPINDLE APPARATUS; NUCLEAR PROTEINS;

EID: 84862302002     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.364356     Document Type: Article

References (29)

1. Pesin, J. A., and Orr-Weaver, T. L. (2008) Regulation of APC/C activators in mitosis and meiosis. Annu. Rev. Cell Dev. Biol. 24, 475-499
2. Musacchio, A., and Salmon, E. D. (2007) The spindle assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 8, 379-393 (Pubitemid 46643240)
3. Vigneron, S., Prieto, S., Bernis, C., Labbé, J. C., Castro, A., and Lorca, T. (2004) Kinetochore localization of spindle checkpoint proteins: who controls whom? Mol. Biol. Cell 15, 4584-4596 (Pubitemid 39299106)
4. Luo, X., Tang, Z., Rizo, J., and Yu, H. (2002) The Mad2 spindle checkpoint protein undergoes similar major conformational changes upon binding to either Mad1 or Cdc20. Mol. Cell 9, 59-71 (Pubitemid 34127771)
5. Habu, T., Kim, S. H., Weinstein, J., and Matsumoto, T. (2002) Identification of a MAD2-binding protein, CMT2, and its role in mitosis. EMBO J. 21, 6419-6428 (Pubitemid 35448420)
6. comet antagonizes the function of Mad2 in the spindle checkpoint. EMBO J. 23, 3133-3143
7. Chan, Y. W., Ma, H. T., Wong, W., Ho, C. C., On, K. F., and Poon, R. Y. (2008) CDK1 inhibitors antagonize the immediate apoptosis triggered by spindle disruption but promote apoptosis following the subsequent rereplication and abnormal mitosis. Cell Cycle 7, 1449-1461 (Pubitemid 351872584)
8. Varetti, G., Guida, C., Santaguida, S., Chiroli, E., and Musacchio, A. (2011) Homeostatic control of mitotic arrest. Mol. Cell 44, 710-720
9. comet blocks Mad2 activation through structural mimicry. Cell 131, 744-755
10. comet. EMBO J. 25, 1273-1284
11. comet-mediated extraction of Mad2 from the MCC promotes efficient mitotic exit. J. Cell Sci. 124, 3905-3916
12. comet promotes disassembly of the mitotic checkpoint complex in an ATP-dependent process. Proc. Natl. Acad. Sci. U.S.A. 108, 3187-3192
13. Chow, J. P. H., and Poon, R. Y. C. (2010) in Cell Cycle Deregulation in Cancer (Enders, G., ed) pp. 79-96, Springer, New York
14. Gascoigne, K. E., and Taylor, S. S. (2008) Cancer cells display profound intra- and interline variation following prolonged exposure to antimitotic drugs. Cancer Cell 14, 111-122
15. Rieder, C. L., and Maiato, H. (2004) Stuck in division or passing through: what happens when cells cannot satisfy the spindle assembly checkpoint. Dev. Cell 7, 637-651 (Pubitemid 39462685)
16. Weaver, B. A., and Cleveland, D. W. (2005) Decoding the links between mitosis, cancer, and chemotherapy: the mitotic checkpoint, adaptation, and cell death. Cancer Cell 8, 7-12 (Pubitemid 40991810)
17. Fung, T. K., Yam, C. H., and Poon, R. Y. (2005) The N-terminal regulatory domain of cyclin A contains redundant ubiquitination targeting sequences and acceptor sites. Cell Cycle 4, 1411-1420 (Pubitemid 41437132)
18. Yam, C. H., Siu, W. Y., Lau, A., and Poon, R. Y. (2000) Degradation of cyclin A does not require its phosphorylation by CDC2 and cyclin-dependent kinase 2. J. Biol. Chem. 275, 3158-3167 (Pubitemid 30083014)
19. 2 DNA damage checkpoint by UCN-01. Mol. Cancer Ther. 10, 784-794
20. Arooz, T., Yam, C. H., Siu, W. Y., Lau, A., Li, K. K., and Poon, R. Y. (2000) On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells. Biochemistry 39, 9494-9501 (Pubitemid 30626339)
21. Ausubel, F., Brent, R., Kingston, R., Moore, D., Seidman, J., Smith, J., and Struhl, K. (1991) Current Protocols in Molecular Biology, John Wiley &Sons, New York
22. Poon, R. Y., Toyoshima, H., and Hunter, T. (1995) Redistribution of the CDKinhibitor p27 between different cyclin-CDK complexes in the mouse fibroblast cell cycle and in cells arrested with lovastatin or ultraviolet irradiation. Mol. Biol. Cell 6, 1197-1213
23. β-TrCP1-EMI1-anaphase-promoting complex/cyclosome axis to promote genome reduplication in the absence of mitosis. Mol. Cell. Biol. 29, 6500-6514
24. Siu, W. Y., Arooz, T., and Poon, R. Y. (1999) Differential responses of proliferating versus quiescent cells to adriamycin. Exp. Cell Res. 250, 131-141 (Pubitemid 29391577)
25. Siu, W. Y., Lau, A., Arooz, T., Chow, J. P., Ho, H. T., and Poon, R. Y. (2004) Topoisomerase poisons differentially activate DNA damage checkpoints through ataxia-telangiectasia mutated-dependent and -independent mechanisms. Mol. Cancer Ther. 3, 621-632 (Pubitemid 39193741)
26. 2-M by mechanisms fundamentally different from other cyclins. J. Biol. Chem. 277, 35140-35149
27. Ma, H. T., and Poon, R. Y. (2011) Orderly inactivation of the key checkpoint protein mitotic arrest-deficient 2 (MAD2) during mitotic progression. J. Biol. Chem. 286, 13052-13059
28. Wong, J., and Fang, G. (2006) HURP controls spindle dynamics to promote proper interkinetochore tension and efficient kinetochore capture. J. Cell Biol. 173, 879-891
29. Jordan, M. A., and Wilson, L. (2004) Microtubules as a target for anticancer drugs. Nat. Rev. Cancer 4, 253-265 (Pubitemid 38525281)